Trials / Completed
CompletedNCT00250211
Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
Multimodality Functional Imaging (MRS and Tumor Perfusion) Predicts Tumor Migration, Invasiveness, and Patterns of Failure of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- AHS Cancer Control Alberta · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to learn whether 3 tesla (3T) MRI functional imaging will map a tumor more accurately allowing a more targeted delivery of radiation. The investigators hope to learn whether tomotherapy will be able to deliver higher radiation doses safely to the tumor while sparing the surrounding normal tissue.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Functional MRI imaging and tomotherapy |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2011-03-01
- Completion
- 2011-04-01
- First posted
- 2005-11-08
- Last updated
- 2016-02-24
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00250211. Inclusion in this directory is not an endorsement.